Cytosorbents Corporation (CTSO)
NASDAQ: CTSO
· Real-Time Price · USD
1.00
0.02 (1.79%)
At close: Sep 09, 2025, 3:59 PM
1.00
0.00%
After-hours: Sep 09, 2025, 04:10 PM EDT
Cytosorbents Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Grant income Revenue | 777.59K | 1.05M | 796.77K | 59.33K | 1.06M | 6.58K | 3.77K | 245.51K | 191.47K | 292.63K |
| Grant income Revenue Growth | -26.14% | +32.14% | +1242.90% | -94.39% | +15953.94% | +74.62% | -98.46% | +28.22% | -34.57% | n/a |
| Other sales Revenue | 26.52K | 11.4K | 24.73K | n/a | 44.93K | n/a | n/a | n/a | n/a | n/a |
| Other sales Revenue Growth | +132.68% | -53.91% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Other Countries Revenue | 6.2M | 5.87M | 5.55M | 5.41M | 6.02M | 5.41M | 8.59M | 4.77M | 4.9M | 4.57M | 1.75M | 3.77M | 4.04M | 3.93M | 3.92M | 4.66M |
| All Other Countries Revenue Growth | +5.67% | +5.81% | +2.49% | -10.18% | +11.32% | -36.98% | +79.97% | -2.57% | +7.20% | +161.28% | -53.61% | -6.64% | +2.77% | +0.13% | -15.84% | n/a |
| Germany Revenue | 3.35M | 2.8M | 3.55M | 3.18M | 2.78M | 3.54M | 6.46M | 2.94M | 3.17M | 3.34M | n/a | 2.49M | 2.98M | 3.78M | 5.33M | 3.66M |
| Germany Revenue Growth | +19.98% | -21.29% | +11.68% | +14.48% | -21.46% | -45.22% | +119.87% | -7.29% | -5.08% | n/a | n/a | -16.42% | -21.16% | -28.98% | +45.47% | n/a |
| United States Revenue | 61K | 62.61K | n/a | 777.59K | 1.05M | 796.77K | 2.38M | 1.06M | 1.35M | 1.54M | n/a | 200.47K | 310.63K | 212.34K | 446.74K | 577.45K |
| United States Revenue Growth | -2.57% | n/a | -100.00% | -26.14% | +32.14% | -66.47% | +124.88% | -21.62% | -12.41% | n/a | n/a | -35.46% | +46.29% | -52.47% | -22.64% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.17M | 8.43M | 9.83M | 7.76M | 8.4M | 9.28M | 9.24M | 9.21M | 8.91M | 9.13M | 8.71M | 9.34M | 9.12M | 9.96M | 11.08M | 8.44M | 10.54M | 8.42M | 9.38M | 7.86M | 7.44M | 6.84M | 7.21M | 6.84M | 5.1M | 5.32M | 7.16M | 4.46M | 6.58M | 4.68M | 4.77M | 3.81M | 3.93M | 2.95M | 4.69M | 2.42M | 2.63M | 2.23M | 2.37M | 1.99M | 1.92M | 2.18M |
| Selling, General, and Administrative Revenue Growth | +8.72% | -14.25% | +26.67% | -7.61% | -9.49% | +0.44% | +0.37% | +3.36% | -2.45% | +4.84% | -6.78% | +2.48% | -8.47% | -10.12% | +31.31% | -19.91% | +25.21% | -10.23% | +19.27% | +5.71% | +8.79% | -5.17% | +5.37% | +34.18% | -4.16% | -25.69% | +60.63% | -32.29% | +40.70% | -1.85% | +24.98% | -2.92% | +33.29% | -37.22% | +93.97% | -7.81% | +17.98% | -6.04% | +19.05% | +3.38% | -11.70% | n/a |
| Research and Development Revenue | 1.26M | 1.66M | 1.3M | 1.85M | 1.52M | 2.25M | 4.1M | 3.75M | 3.67M | 4.21M | 3.4M | 3.29M | 4.18M | 4.24M | 6.14M | 4.26M | 3.7M | 2.28M | 2.69M | 1.75M | 2.41M | 1.97M | 3.56M | 3.19M | 2.93M | 2.42M | 2.42M | 1.94M | 1.58M | 1.78M | 2.42M | 537.95K | 487.61K | 469.55K | 1.66M | 1.17M | 1.09M | 856.12K | 1.25M | 866.33K | 801.66K | 951.03K |
| Research and Development Revenue Growth | -24.11% | +28.22% | -29.93% | +21.78% | -32.38% | -45.12% | +9.26% | +2.18% | -12.93% | +23.87% | +3.40% | -21.35% | -1.41% | -30.86% | +43.99% | +15.22% | +62.09% | -15.04% | +53.14% | -27.10% | +22.44% | -44.77% | +11.71% | +8.70% | +21.12% | -0.21% | +24.76% | +23.29% | -11.46% | -26.48% | +350.04% | +10.32% | +3.85% | -71.77% | +41.89% | +7.33% | +27.55% | -31.62% | +44.52% | +8.07% | -15.71% | n/a |